Decreased DHRS2 expression is associated with HDACi resistance and poor prognosis in ovarian cancer
出版年份 2019 全文链接
标题
Decreased DHRS2 expression is associated with HDACi resistance and poor prognosis in ovarian cancer
作者
关键词
-
出版物
Epigenetics
Volume -, Issue -, Pages 1-12
出版商
Informa UK Limited
发表日期
2019-08-19
DOI
10.1080/15592294.2019.1656155
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Epigenetic therapy for ovarian cancer: promise and progress
- (2019) Sara Moufarrij et al. Clinical Epigenetics
- HOXA13 contributes to gastric carcinogenesis through DHRS2 interacting with MDM2 and confers 5-FU resistance by a p53-dependent pathway
- (2018) Yang Han et al. MOLECULAR CARCINOGENESIS
- Deregulated expression of HDAC3 in colorectal cancer and its clinical significance
- (2018) Masoumeh Nemati et al. Advances in Clinical and Experimental Medicine
- The Search for Potent, Small-Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat
- (2017) Chiara Zagni et al. MEDICINAL RESEARCH REVIEWS
- DHRS2 inhibits cell growth and motility in esophageal squamous cell carcinoma
- (2017) Y Zhou et al. ONCOGENE
- Histone deacetylases inhibitors (HDACis) as novel therapeutic application in various clinical diseases
- (2017) Xiaoyan Qiu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Epigenetics in ovarian cancer
- (2017) Yanina Natanzon et al. SEMINARS IN CANCER BIOLOGY
- Inhibitors of histone deacetylase as antitumor agents: A critical review
- (2016) Mohammed Manal et al. BIOORGANIC CHEMISTRY
- Inside HDACs with more selective HDAC inhibitors
- (2016) Joëlle Roche et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Correlating chemical sensitivity and basal gene expression reveals mechanism of action
- (2015) Matthew G Rees et al. Nature Chemical Biology
- HDAC Family Members Intertwined in the Regulation of Autophagy: A Druggable Vulnerability in Aggressive Tumor Entities
- (2015) Emily Koeneke et al. Cells
- Suppression of Annexin A11 in Ovarian Cancer: Implications in Chemoresistance
- (2015) Jin Song et al. NEOPLASIA
- Proteomic Identification of Pterostilbene-Mediated Anticancer Activities in HepG2 Cells
- (2014) N. Suganya et al. CHEMICAL RESEARCH IN TOXICOLOGY
- The Therapeutic Potential of Class I Selective Histone Deacetylase Inhibitors in Ovarian Cancer
- (2014) Dineo Khabele Frontiers in Oncology
- Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer
- (2013) Teng Ji et al. CANCER LETTERS
- An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules
- (2013) Amrita Basu et al. CELL
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Development of a gene expression database and related analysis programs for evaluation of anticancer compounds
- (2012) Masaru Ushijima et al. CANCER SCIENCE
- MYC directs transcription of MCL1 and eIF4E genes to control sensitivity of gastric cancer cells toward HDAC inhibitors
- (2012) Wajana L. Labisso et al. CELL CYCLE
- Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients
- (2012) Balázs Győrffy et al. ENDOCRINE-RELATED CANCER
- Recent progress in the diagnosis and treatment of ovarian cancer
- (2011) Danijela Jelovac et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer epigenetics reaches mainstream oncology
- (2011) Manuel Rodríguez-Paredes et al. NATURE MEDICINE
- Mitochondrial HEP27 Is a c-Myb Target Gene That Inhibits Mdm2 and Stabilizes p53
- (2010) C. Deisenroth et al. MOLECULAR AND CELLULAR BIOLOGY
- Expression of Hypoxia-Inducible Factor-1α, Histone Deacetylase 1, and Metastasis-Associated Protein 1 in Pancreatic Carcinoma
- (2009) Kotaro Miyake et al. PANCREAS
- Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells
- (2008) Michela Muscolini et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search